Insiders / Zante Greg / Activity
Activity — Zante Greg
7 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 5, 2026 | Sell | VKTX Viking Therapeutics Inc Common Stock, par value $0.00001 per share | $1.03M | -32K -12.91% | 215,571 0.18% of shares | medium |
| Jan 5, 2026 | Sell | VKTX Viking Therapeutics Inc Common Stock, par value $0.00001 per share | $464.0K | -14K -6.45% | 201,671 0.17% of shares | medium |
| Jan 5, 2026 | Sell | VKTX Viking Therapeutics Inc Common Stock, par value $0.00001 per share | $352.6K | -10K -5.11% | 191,371 0.16% of shares | medium |
| Jan 5, 2026 | Sell | VKTX Viking Therapeutics Inc Common Stock, par value $0.00001 per share | $48.1K | -2K -0.78% | 189,891 0.16% of shares | low |
| Jan 2, 2026 | Grant | VKTX Viking Therapeutics Inc Common Stock, par value $0.00001 per share | $0 | +32K +14.87% | 247,532 0.21% of shares | low |
| Jan 2, 2026 | Grant | VKTX Viking Therapeutics Inc Common Stock, par value $0.00001 per share | $0 | +41K +23.50% | 215,483 0.18% of shares | low |
| Jan 2, 2026 | Grant | VKTX Viking Therapeutics Inc Stock Option (Right to Buy) | — | +91K | 91,000 0.08% of shares | low |